VJO Canada Inc. (VJO), conveniently located in the epicenter of global CRO excellence, Montreal, Quebec (Canada). Established in 2016,

VJO is a drug development accelerator company specializing in all stages of drug development and focused on accelerating virtual, small, and medium biotech intellectual properties in parallel to their imminent exit strategies - navigating your IP from nonclinical proof of concept to becoming a Phase 2 ready drug.

VJO Canada has pioneered a resourceful model that facilitates the reduction of overhead costs, target milestone delivery, and overall burn rate for biotech entities.

We have created an intellectual paradigm supported by the foundation of an optimized project management process, a regulatory compliance management system, and an assortment of strategies to achieve significant cost and time efficiencies.

This proven strategy empowers our expert drug development navigators, business development strategists, and subject matter experts (SME) to focus on the critical path that facilitates deployment for proficient planning of drug development programs.

Our board certified experts are successful executives that have originated from big pharma, biotech, and contract research organizations with more than 100 years of combined drug development experience, they will help navigate your program towards your exit strategy.

VJO Canada puts faith in the paradigm of people, partnerships, and performance. We believe that “we are only as good as our team.”

Our core service offerings revolve around our industry-leading multidisciplinary team that will support biotech drug development endeavors from the selection of lead drug candidates following through to clinical proof of concept covering the following areas:

● Outsourcing/ Project Management/ Monitoring – Continental & International – by Board Certified Multidisciplinary Subject Matter Experts

● Product development and registration strategies

● Scientific/Medical Writing by qualified experts

● Nonclinical/Clinical

● Bioanalytical/ Analytical/ Immunology

● Chemistry and Manufacturing

● Investigator's Brochures

● Data review and gap analyses

● Scientific and Regulatory due diligence

● Investment Strategies (In-Licensing, Technology Transfer, Dilutive/Non-Dilutive Funding)

● Project Monitoring & Management

● Toxicology Subject Matter Experts (SME) in a wide array of therapeutic targets

● GLP support (inspections, study monitoring, and SOP review and preparation)

● Selection of appropriate laboratories (SWOT analysis of vendor options)

● Developing and reviewing toxicology protocols, study designs, and draft reports

● Impurity assessment and qualification

● Literature-based safety reviews and risk assessments

● On site vendor qualification and execution of quality assurance/ auditing activities

● Interaction with regulatory authorities on behalf of clients;

● Paper and Electronic applications to support;

● Clinical trials;

● Marketing applications; and,

● Post-approval and lifecycle management;

● Support for regulatory consultation meetings;

● Regulatory strategy;

● Identifying opportunities for expedited approval; Issue resolution;

● Negotiations; and,

● Act as US agent and Canadian regulatory representative